Literature DB >> 3470803

Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein.

S Karlsson, T Papayannopoulou, S G Schweiger, G Stamatoyannopoulos, A W Nienhuis.   

Abstract

A high-titer amphotropic retroviral vector containing the neomycin resistance gene and a hybrid gamma-beta genomic human globin gene has been constructed. Mouse erythroleukemia cells infected with this virus were found to contain the full transcriptional unit of the transferred human globin gene by Southern blot analysis. These cells contain normally initiated, spliced, and terminated human globin mRNA. The human globin mRNA level increased 5- to 10-fold upon induction of the mouse erythroleukemia cells. Human globin chains were produced but only in a fraction of the cells as detected by immunofluorescent staining. A similar retrovirus containing a human beta-globin gene was used to transduce mouse erythroleukemia cells resulting in much higher levels of human globin synthesis than detected in mouse erythroleukemia cells transduced with the gamma-beta globin virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3470803      PMCID: PMC304661          DOI: 10.1073/pnas.84.8.2411

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Regulated expression of a complete human beta-globin gene encoded by a transmissible retrovirus vector.

Authors:  R D Cone; A Weber-Benarous; D Baorto; R C Mulligan
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

2.  Infectious and selectable retrovirus containing an inducible rat growth hormone minigene.

Authors:  A D Miller; E S Ong; M G Rosenfeld; I M Verma; R M Evans
Journal:  Science       Date:  1984-09-07       Impact factor: 47.728

3.  DNA sequences required for regulated expression of beta-globin genes in murine erythroleukemia cells.

Authors:  S Wright; A Rosenthal; R Flavell; F Grosveld
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

4.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

Review 5.  Form and function of retroviral proviruses.

Authors:  H E Varmus
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

6.  Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector.

Authors:  K Shimotohno; H M Temin
Journal:  Nature       Date:  1982-09-16       Impact factor: 49.962

7.  Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse.

Authors:  D A Williams; I R Lemischka; D G Nathan; R C Mulligan
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

8.  Monoclonal antibodies specific for globin chains.

Authors:  G Stamatoyannopoulos; M Farquhar; D Lindsley; M Brice; T Papayannopoulou; P E Nute
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

9.  Amphotropic retrovirus vector system for human cell gene transfer.

Authors:  J Sorge; D Wright; V D Erdman; A E Cutting
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  29 in total

Review 1.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  An Erythroid-Specific Chromatin Opening Element Increases β-Globin Gene Expression from Integrated Retroviral Gene Transfer Vectors.

Authors:  Michael J Nemeth; Christopher H Lowrey
Journal:  Gene Ther Mol Biol       Date:  2004-12

Review 3.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

4.  Analysis of enhancer function of the HS-40 core sequence of the human alpha-globin cluster.

Authors:  H Chen; C H Lowrey; G Stamatoyannopoulos
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

Review 5.  Development of gene therapy for thalassemia.

Authors:  Arthur W Nienhuis; Derek A Persons
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

6.  Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.

Authors:  P H Correll; J K Fink; R O Brady; L K Perry; S Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

7.  Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.

Authors:  J K Fink; P H Correll; L K Perry; R O Brady; S Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 8.  Gene therapy for hemoglobinopathies: the state of the field and the future.

Authors:  Shanmuganathan Chandrakasan; Punam Malik
Journal:  Hematol Oncol Clin North Am       Date:  2014-04       Impact factor: 3.722

9.  High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells.

Authors:  U Novak; E A Harris; W Forrester; M Groudine; R Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 10.  Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting.

Authors:  W Walther; U Stein
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.